[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2001 [#4]

Announcement Date
20-Feb-2002
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2001
Quarter
31-Dec-2001 [#4]
Profit Trend
QoQ- 1.99%
YoY- 24.18%
Quarter Report
View:
Show?
Annualized Quarter Result
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
Revenue 607,266 596,192 562,704 543,496 538,640 525,406 523,984 10.32%
PBT 66,510 60,716 53,968 51,604 48,920 47,300 52,012 17.79%
Tax -25,761 -23,738 -24,600 -20,800 -18,716 -17,272 -18,148 26.27%
NP 40,749 36,978 29,368 30,804 30,204 30,028 33,864 13.11%
-
NP to SH 40,749 36,978 29,368 30,804 30,204 30,028 33,864 13.11%
-
Tax Rate 38.73% 39.10% 45.58% 40.31% 38.26% 36.52% 34.89% -
Total Cost 566,517 559,214 533,336 512,692 508,436 495,378 490,120 10.12%
-
Net Worth 172,567 159,405 167,817 160,520 152,020 144,134 140,265 14.80%
Dividend
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
Div 1,667 - - 3,750 - - - -
Div Payout % 4.09% - - 12.18% - - - -
Equity
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
Net Worth 172,567 159,405 167,817 160,520 152,020 144,134 140,265 14.80%
NOSH 50,019 49,970 49,945 50,006 50,006 50,046 50,094 -0.09%
Ratio Analysis
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
NP Margin 6.71% 6.20% 5.22% 5.67% 5.61% 5.72% 6.46% -
ROE 23.61% 23.20% 17.50% 19.19% 19.87% 20.83% 24.14% -
Per Share
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
RPS 1,214.06 1,193.09 1,126.63 1,086.85 1,077.14 1,049.83 1,045.99 10.43%
EPS 81.47 74.00 58.80 61.60 60.40 60.00 67.60 13.23%
DPS 3.33 0.00 0.00 7.50 0.00 0.00 0.00 -
NAPS 3.45 3.19 3.36 3.21 3.04 2.88 2.80 14.91%
Adjusted Per Share Value based on latest NOSH - 50,006
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
RPS 42.13 41.37 39.04 37.71 37.37 36.45 36.36 10.30%
EPS 2.83 2.57 2.04 2.14 2.10 2.08 2.35 13.17%
DPS 0.12 0.00 0.00 0.26 0.00 0.00 0.00 -
NAPS 0.1197 0.1106 0.1164 0.1114 0.1055 0.10 0.0973 14.79%
Price Multiplier on Financial Quarter End Date
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
Date 30/09/02 28/06/02 29/03/02 31/12/01 27/09/01 29/06/01 30/03/01 -
Price 7.68 7.32 7.32 7.27 5.73 6.36 6.82 -
P/RPS 0.63 0.61 0.65 0.67 0.53 0.61 0.65 -2.06%
P/EPS 9.43 9.89 12.45 11.80 9.49 10.60 10.09 -4.40%
EY 10.61 10.11 8.03 8.47 10.54 9.43 9.91 4.65%
DY 0.43 0.00 0.00 1.03 0.00 0.00 0.00 -
P/NAPS 2.23 2.29 2.18 2.26 1.88 2.21 2.44 -5.81%
Price Multiplier on Announcement Date
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
Date 22/11/02 26/08/02 21/05/02 20/02/02 26/11/01 29/08/01 24/05/01 -
Price 7.36 7.86 7.86 6.77 6.82 6.82 6.77 -
P/RPS 0.61 0.66 0.70 0.62 0.63 0.65 0.65 -4.14%
P/EPS 9.03 10.62 13.37 10.99 11.29 11.37 10.01 -6.63%
EY 11.07 9.41 7.48 9.10 8.86 8.80 9.99 7.07%
DY 0.45 0.00 0.00 1.11 0.00 0.00 0.00 -
P/NAPS 2.13 2.46 2.34 2.11 2.24 2.37 2.42 -8.15%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment